Multiple myeloma
- 1 March 2004
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 363 (9412) , 875-887
- https://doi.org/10.1016/s0140-6736(04)15736-x
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaBlood, 2002
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998
- Myeloma bone diseaseEuropean Journal Of Cancer, 1998
- Should alpha-interferon be included as standard treatment in multiple myeloma?European Journal Of Cancer, 1998
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Changing clinical presentation of multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1991
- INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMAThe Lancet, 1989
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981